Why is Exagen, Inc. ?
1
Poor long term growth as Operating profit has grown by an annual rate 1.43% of over the last 5 years
2
Flat results in Mar 26
- INTEREST(HY) At USD 2.6 MM has Grown at 134.39%
- NET PROFIT(HY) At USD -10.42 MM has Grown at -38.75%
- ROCE(HY) Lowest at -193.58%
3
Risky -
- The stock is trading risky as compared to its average historical valuations
- Over the past year, while the stock has generated a return of -37.52%, its profits have fallen by -20%
4
Underperformed the market in the last 1 year
- Even though the market (S&P 500) has generated returns of 22.24% in the last 1 year, the stock has hugely underperformed and has generate negative returns of -37.52% returns
How much should you sell?
- All quantity irrespective of whether you are making profits or losses
(If sector exposure > 30%, please use optimiser tool to see which are the best stocks to hold in Pharmaceuticals & Biotechnology)
When to re-enter? - We will constantly monitor the company and review our call based on new data
Is Exagen, Inc. for you?
High Risk, High Return
Absolute
Risk Adjusted
Volatility
Exagen, Inc.
-37.52%
1.64
72.49%
S&P 500
22.24%
1.67
13.28%
Quality key factors
Factor
Value
Sales Growth (5y)
9.66%
EBIT Growth (5y)
1.43%
EBIT to Interest (avg)
-9.36
Debt to EBITDA (avg)
Negative Net Debt
Net Debt to Equity (avg)
1.70
Sales to Capital Employed (avg)
1.48
Tax Ratio
0.08%
Dividend Payout Ratio
0
Pledged Shares
0
Institutional Holding
59.95%
ROCE (avg)
0
ROE (avg)
0
Valuation Key Factors 
Factor
Value
P/E Ratio
NA (Loss Making)
Industry P/E
Price to Book Value
3.69
EV to EBIT
-4.09
EV to EBITDA
-4.81
EV to Capital Employed
5.48
EV to Sales
0.86
PEG Ratio
NA
Dividend Yield
NA
ROCE (Latest)
-134.04%
ROE (Latest)
-104.02%
Technical key factors
Indicator
Weekly
Monthly
MACD
Mildly Bullish
Mildly Bearish
RSI
No Signal
No Signal
Bollinger Bands
Mildly Bearish
Mildly Bearish
Moving Averages
Bearish (Daily)
KST
Mildly Bullish
Mildly Bearish
Dow Theory
Mildly Bullish
No Trend
OBV
Mildly Bullish
No Trend
Technical Movement
8What is working for the Company
OPERATING CASH FLOW(Y)
Highest at USD -13.37 MM
NET PROFIT(HY)
Higher at USD -10.42 MM
RAW MATERIAL COST(Y)
Fallen by -0.17% (YoY
NET SALES(Q)
Highest at USD 17.31 MM
EPS(Q)
Highest at USD -0.17
-14What is not working for the Company
INTEREST(HY)
At USD 2.6 MM has Grown at 134.39%
NET PROFIT(HY)
At USD -10.42 MM has Grown at -38.75%
ROCE(HY)
Lowest at -193.58%
INVENTORY TURNOVER RATIO(HY)
Lowest at 6.44 times
Here's what is working for Exagen, Inc.
Net Profit
Higher at USD -10.42 MM
than preceding 12 month period ended Mar 2026MOJO Watch
In the half year the company has already crossed Net Profit of the previous twelve months
Net Profit (USD MM)
Operating Cash Flow
Highest at USD -13.37 MM
in the last three yearsMOJO Watch
The company has generated higher cash revenues from business operations
Operating Cash Flows (USD MM)
Net Sales
Highest at USD 17.31 MM
in the last five periodsMOJO Watch
Near term sales trend is positive
Net Sales (USD MM)
EPS
Highest at USD -0.17
in the last five periodsMOJO Watch
Increasing profitability; company has created higher earnings for shareholders
EPS (USD)
Raw Material Cost
Fallen by -0.17% (YoY)
MOJO Watch
The company's ability to pass on the cost of raw materials to customers has improved; this may lead to a rise in profit margin
Raw Material Cost as a percentage of Sales
Here's what is not working for Exagen, Inc.
Interest
At USD 2.6 MM has Grown at 134.39%
over previous Semi-Annual periodMOJO Watch
Rising interest cost signifies increased borrowings
Interest Paid (USD MM)
Net Profit
At USD -10.42 MM has Grown at -38.75%
Year on Year (YoY)MOJO Watch
Near term Net Profit trend is very negative
Net Profit (USD MM)
Inventory Turnover Ratio
Lowest at 6.44 times
in the last five Semi-Annual periodsMOJO Watch
Company's pace of selling inventory has slowed
Inventory Turnover Ratio






